A Systematic Review and Meta-analysis of the Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Gastric Cancer (original) (raw)

• Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003;56:1–9
  Article PubMed Google Scholar
• Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33–64
  Article PubMed CAS Google Scholar
• Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106–30
  Article PubMed Google Scholar
• Ohtsu A, Yoshida S, Saijo N. Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol 2006;24:2188–96
  Article PubMed Google Scholar
• NHS Centre for Reviews and Dissemination. Undertaking Systemic Reviews of Research on Effectiveness: CRD’s Guidance for those Carrying Out or Commissioning Reviews. CRD Report 4 (2nd edn). York: NHS Centre for Reviews and Dissemination; 2001
• Dixon E, Hameed M, Sutherland F, et al. Evaluating meta-analyses in the general surgical literature: a critical appraisal. Ann Surg 2005;241:450–9
  Article PubMed Google Scholar
• Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815–34
  Article PubMed CAS Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–188
  Article PubMed CAS Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34
  PubMed CAS Google Scholar
• Higgins J, Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–58
  Article PubMed Google Scholar
• Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer - final results of a randomised controlled study. Cancer 1994;73:2048–52
  Article PubMed CAS Google Scholar
• Fujimoto S, Takahashi M, Mutou T, et al. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 1999;85:529–34
  Article PubMed CAS Google Scholar
• Yonemura Y, de Aretxabala X, Fujimura T, et al. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomised controlled study. Hepatogastroenterol 2001;48:1776–82
  CAS Google Scholar
• Zhang W, Su D, Wang K, et al. Clinical study in prophylactic use of intraperitoneal hyperthermic chemoperfusion for the prevention of peritoneal metastasis in patients with advanced gastric carcinoma. Shanxi Yiyao Zazhi 1998;27:67–9
  Google Scholar
• Takahashi T, Hagiwara A, Shimotsuma M, et al. Prophylaxis and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles. World J Surg 1995;19:565–9
  Article PubMed CAS Google Scholar
• Shimoyama S, Shimizu N, Kaminishi M. Type-oriented intraoperative and adjuvant chemotherapy and survival after curative resection of advanced gastric cancer. World J Surg 1999;23:284–91
  Article PubMed CAS Google Scholar
• Miyashiro I, Furukawa H, Sasako M, et al. No survival benefit with adjuvant chemotherapy for serosal-positive gastric cancer: Randomised trial of adjuvant chemotherapy with cisplatin followed by oral fluorouracil in serosa-positive gastric cancer - Japan Clinical Oncology Group 9206-2. Proc ASCO-GI 84 (abstr 4), 2005
• Rosen HR, Jatzko G, Repse S, et al. Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomised multi-center trial of the Austrian Working Group for Surgical Oncology. J Clin Oncol 1998;16:2733–8
  PubMed CAS Google Scholar
• Yu W, Whang I, Chung HY, et al. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomised trial. World J Surg 2001;25:985–90
  Article PubMed CAS Google Scholar
• Wei G, Fang GE, Bi JW, et al. Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer. Ai Zheng 2005;24:478–82
  PubMed Google Scholar
• Gao Z, Jiang Z, Zhou F. Clinical surgery of early intraperitoneal hyperthermic chemoperfusion for gastric cancer patients after operation. Zhonggou Zhongliu Linchuang 2002;29:294–5
  Google Scholar
• Sautner T, Hofbauer F, Depisch D, et al. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J Clin Oncol 1994;12:970–4
  PubMed CAS Google Scholar
• Zuo Y, Xu M, Shen D, et al. Postoperative intraperitioneal hyperthermic chemoperfusion combined with intravenous chemotherapy for 82 advanced gastric cancer patients. Zhonghua Zhongliu Zazhi 2004;26:247–9
  PubMed Google Scholar
• Tan C, Wang X, Xu Y, et al. Study for prevention of peritoneal dissemination of advanced gastric cancer by intraperitoneal thermochemotherapy. Shiyong Zhongliu Zazhi 2000;15:165–7
  Google Scholar
• Ikeguchi M, Kondou A, Oka A, et al. Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion. Eur J Surg 1995;161:581–6
  PubMed CAS Google Scholar
• Kaibara N, Hamazoe R, Iitsuka Y, et al. Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer. Hepatogastroenterol 1989;36:75–8
  CAS Google Scholar
• Koga S, Hamazoe R, Maeta M, et al. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988;61:232–7
  Article PubMed CAS Google Scholar
• Fujimura T, Yonemura Y, Muraoka K, et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomised controlled study. World J Surg 1994;18:150–5
  Article PubMed CAS Google Scholar
• Hagiwara A, Takahashi T, Kojima O, et al. Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet 1992;339:629–1
  Article PubMed CAS Google Scholar
• Takahashi T, Hagiwara A, Shimotsuma M. Intraperitoneal chemotherapy with mitomycin C bound to activated carbon particles for patients with advanced gastric cancer. Eur J Surg Oncol 1994;20:183–4
  PubMed CAS Google Scholar
• Yu W, Whang I, Averbach A, et al. Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancer. Am Surg 1998;64:1104–8
  PubMed CAS Google Scholar
• Yu W, Whang I, Suh I, et al. Prospective randomised trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 1998;228:347–54
  Article PubMed CAS Google Scholar
• Yu W, Sugarbaker P, Whang I. Randomised controlled trial of early postoperative intraperitoneal chemotherapy in gastric cancer: a preliminary report. Reg Cancer Treat 1994;2:90–3
  Google Scholar
• Schiessel R, Funovics J, Schick B, et al. Adjuvant intraperitoneal cisplatin therapy in patients with operated gastric carcinoma: results of a randomised trial. Acta Med Austriaca 1989;16:68–9
  PubMed CAS Google Scholar
• Xu DZ, Zhan YQ, Sun XW, et al. Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol 2004;10:2727–30
  PubMed Google Scholar
• Weisberger AS, Levine B, Storaasli JP. Use of nitrogen mustard in treatment of serous effusions of neoplastic origin. JAMA 1955;159:1704–7
  CAS Google Scholar
• Jones RB, Myers CE, Guarino AM, et al. High volume intraperitoneal chemotherapy (“belly bath”) for ovarian cancer. Pharmacologic basis and early results. Cancer Chemother Pharmacol 1978;1:161–6
  Article PubMed CAS Google Scholar
• Jaaback K, Johnson N. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database Syst Rev CD005340, 2006
• Verwaal VJ, van Ruth S, de Bree E, et al. Randomised trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737–43
  Article PubMed Google Scholar
• Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 2006;7:69–76
  Article PubMed Google Scholar
• Yan TD, Black D, Savady R, et al. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol doi:10.1245/s10434-006-9182-x, 2006
• Yan TD, Welch L, Black D, et al. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol doi:10.1093/annonc/mdl428, 2006
• Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11–20
  Article PubMed CAS Google Scholar
• MacDonald JS, Malley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725–9
  Article PubMed CAS Google Scholar
• Cascinu S, Labianca R, Barone C, et al Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin and Epidoxorubibin in a randomized controlled trial. J Natl Cancer Inst doi: 10.1093/jnci/djk131, 2007
• Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221:124–32
  Article PubMed CAS Google Scholar
• Los G, Mutsaers PH, Lenglet WJ, et al. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment. Cancer Chemother Pharmacol 1990;25:389–94
  Article PubMed CAS Google Scholar
• Yonemura Y, Kawamura T, Bandou E, et al. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005;92:370–5
  Article PubMed CAS Google Scholar
• Glehen O, Schreiber V, Cotte E, et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 2004;139:20–6
  Article PubMed CAS Google Scholar
• Hall JJ, Loggie BW, Shen P, et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg 2004;8:454–63
  Article PubMed Google Scholar
• Armstrong D, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006;354:77–9
  Article Google Scholar